23.4 C
New York
Wednesday, June 17, 2026

Tag: replay

Saputo Reports Financial Results for the First Quarter of Fiscal 2026 Ended June 30, 2025

MONTRÉAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the first quarter of fiscal 2026, which ended on June 30, 2025. All amounts in this news release are in millions of Canadian dollars (CDN), except per share amounts, unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS).

CAPREIT Reports Second Quarter 2025 Results

TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust ("CAPREIT") (TSX: CAR.UN) announced today its operating and financial results for the three and six months ended June 30, 2025. Management will host a conference call to discuss the financial results on Friday, August 8, 2025 at 9:00 a.m. ET.

Post Holdings Reports Results for the Third Quarter of Fiscal Year 2025; Raises Fiscal Year 2025 Outlook

ST. LOUIS, Aug. 7, 2025 /PRNewswire/ -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the third fiscal quarter...

ATN Reports Second Quarter 2025 Results; Reaffirms 2025 Outlook

Second Quarter 2025 vs. Second Quarter 2024 Financial Highlights

LiqTech to Discuss Second Quarter 2025 Results on Wednesday, August 13, 2025

Management to Host Conference Call on Wednesday, August 13, 2025, at 9:00 a.m. Eastern time
Management to Host Conference Call on Wednesday, August 13, 2025, at 9:00 a.m. Eastern time

VIAVI Announces Fiscal Fourth Quarter and Fiscal Year 2025 Results

CHANDLER, Ariz., Aug. 7, 2025 /PRNewswire/ -- VIAVI (NASDAQ: VIAV) today reported results for its fiscal fourth quarter and fiscal year ended June 28,...

Inseego Reports Second Quarter 2025 Financial Results

Q2 2025 revenue of $40.2 million
Q2 2025 Adjusted EBITDA of $4.7 million and GAAP Net Income of $0.5 million
Paid off $14.9 million balance of 2025 Convertible Notes
Entered into a $15.0 million undrawn working capital facility for further operating flexibility and liquidity

SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins

94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz., Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc....

ePlus Reports First Quarter Fiscal Year 2026 Financial Results

~ Announces Initial Common Stock Quarterly Dividend of $0.25 Per Share and New Stock Repurchase Program ~ First Quarter Fiscal Year 2026 Consolidated net sales increased...

Genpact Reports Second Quarter 2025 Results

Net Revenues of $1.254 billion, Up 6.6% (6.2% constant currency)1Data-Tech-AI Net Revenues of $599 million, Up 9.7% (9.5% constant currency)1Digital Operations Net Revenues of...

AKAMAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

Second quarter revenue of $1.043 billion, up 7% year-over-year and up 6% when adjusted for foreign exchange* Cloud Infrastructure Services** revenue of $71 million, up 30% year-over-year...

Hovnanian Enterprises Announces Third Quarter Fiscal 2025 Earnings Release and Conference Call

MATAWAN, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Hovnanian Enterprises, Inc. (NYSE: HOV), a leading national homebuilder, will release financial results for the third quarter ended July 31, 2025, the morning of Thursday, August 21, 2025. The Company will webcast its third quarter earnings conference call at 11:00 a.m. (ET) on Thursday, August 21, 2025.

Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025

Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel, Aug. 7, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a...

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 14, 2025

FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that the Company will report financial results for the second quarter ended June 30, 2025, and provide a corporate update on August 14, 2025, at 8:30 a.m. Eastern Time.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsReplay